Today: 3 July 2026

Salesforce (CRM) stock steadies after AI selloff jitters — what traders are watching next

Salesforce (CRM) stock steadies after AI selloff jitters — what traders are watching next

NEW YORK, Feb 4, 2026, 11:35 a.m. — Regular session Salesforce shares crept up 0.1% to $196.54 in late-morning trading on Wednesday, rebounding after a roughly 7% drop the day before. The stock bounced between a low of $187.29 and a high of $199.64, with around 11.1 million shares changing hands.
4 February 2026
······
Constellation Software hits a 1-year low — why analysts still see upside in CSU

Constellation Software hits a 1-year low — why analysts still see upside in CSU

Constellation Software shares lingered near the low end of their 52-week range Wednesday, following a sharp decline the previous session. By 10:44 a.m. EST, the stock was changing hands around C$2,342, after falling as low as C$2,215 and closing Tuesday at C$2,288.91. https://stockanalysis.com/quote/tsx/CSU/ This move is significant because Constellation isn’t your usual “one product” software company. It acquires dozens of small, industry-specific software firms and operates them as a portfolio, relying on steady cash flow and strong niche market positions to drive long-term growth.
4 February 2026
·
Qualcomm earnings day: Cantor trims QCOM target to $160 as handset worries return

Qualcomm earnings day: Cantor trims QCOM target to $160 as handset worries return

Cantor Fitzgerald’s C.J. Muse lowered his price target on Qualcomm to $160 from $185, maintaining a Neutral rating ahead of the chipmaker’s quarterly report due Wednesday. Qualcomm shares gained roughly 2.9%, trading at $151.41 in early action. Qualcomm plans to release its fiscal first-quarter earnings after the U.S. market closes on Wednesday, followed by a conference call at 1:45 p.m. Pacific time. The stock remains highly reactive to handset market cues, so the company’s guidance is expected to carry more weight than the actual results.
4 February 2026
···
Novo Nordisk stock plunges as 2026 sales warning fuels price-war fears around Wegovy

Novo Nordisk stock plunges as 2026 sales warning fuels price-war fears around Wegovy

Copenhagen, Feb 4, 2026, 16:49 — Regular session Shares of Novo Nordisk plunged roughly 16% in Copenhagen on Wednesday after the Wegovy maker warned that sales and profits could dip in 2026 amid renewed pressure on U.S. drug prices. Jyske Bank analysts described the revised outlook as “yet another blow” for investors. In New York, the company’s ADRs dropped $1.94, or about 3.9%, to $48.36.
4 February 2026
···
Eli Lilly (LLY) stock price jumps 10% after 2026 outlook; pricing pressure and FDA decision in focus

Eli Lilly (LLY) stock price jumps 10% after 2026 outlook; pricing pressure and FDA decision in focus

New York, Feb 4, 2026, 11:01 EST — Regular session Eli Lilly and Company shares surged about 10% Wednesday after the company released its quarterly earnings and 2026 outlook, sparking renewed enthusiasm for its weight-loss division. The stock climbed to $1,104.94 in late-morning New York trading, bouncing back from a low of $995.88 earlier in the session.
4 February 2026
··
Robinhood stock tumbles with Bitcoin again as HOOD nears earnings and “oversold” alarms blare

Robinhood stock tumbles with Bitcoin again as HOOD nears earnings and “oversold” alarms blare

Shares of Robinhood Markets fell once more on Wednesday, dragged down by another decline in Bitcoin. The stock’s steep retreat shows no signs of easing, unsettling one of the market’s most volatile retail trading names. This shift is crucial as Robinhood approaches its quarterly earnings, with investors zeroing in on whether crypto trades, options volume, and fresh offerings can sustain growth amid lingering risk concerns.
4 February 2026
···
1 … 554 555 556 557 558 … 2,133

Stock Market Today

  • ASX Closes Up; Exchange Pays AU$20.5 Million over Disclosure Case
    July 3, 2026, 2:44 AM EDT. The S&P/ASX 200 Index climbed 1.37% to finish at 8,844.30 as traders bet the US Federal Reserve will keep rates steady after soft US jobs data. ASX agreed to a AU$20.5 million penalty to settle misleading disclosure claims on its tech upgrade delays, with approval from Australia's Federal Court. Suncorp Group flagged higher reinsurance costs for FY27 but said its event retention limits remain unchanged. Genesis Minerals booked gold output of 70,767 ounces for the June quarter, on track with its 2026 outlook of 260,000 to 290,000 ounces at costs between AU$2,500 and AU$2,700 per ounce. S&P Global Services PMI ticked up to 50.5, pointing to a small rebound in local business activity.
Go toTop